Rx Fraud Investigations Could Get Boost From Health Care Reform's Transparency Requirements
This article was originally published in The Pink Sheet Daily
Executive Summary
Former DoJ prosecutor Michael Loucks says there is pressure from Congress to exclude companies from government programs, particularly if they have prior settlements with the government.